{"id":"W2810108141","doi":"10.1212/wnl.90.15_supplement.p6.363","title":"Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS II Extension (P6.363)","year":2018,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Alemtuzumab; Relapsing remitting; Medicine; Disease; Glatiramer acetate; Dimethyl fumarate; Internal medicine; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002549854,0.0006519905,0.001331298,0.0003375951,0.0003735692,0.000588064,0.0005272376,0.0008019246,0.0008781131],"category_scores_gemma":[0.002193507,0.0001953986,0.001234392,0.0005262167,0.0004256181,0.0004919122,0.0002951706,0.001077035,0.0002407216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000698437,"about_ca_system_score_gemma":0.001028255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002187729,"about_ca_topic_score_gemma":0.002975863,"domain_scores_codex":[0.9990948,0.0005049401,0.00007994655,0.0001080809,0.00008955784,0.0001227],"domain_scores_gemma":[0.9986418,0.0003326473,0.0003582493,0.0001085613,0.000113673,0.0004451308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8256849,0.01480038,0.08722673,0.0005156643,0.002486812,0.0002027866,0.0002804413,0.0007105805,0.00856868,0.00008393915,0.001006814,0.05843228],"study_design_scores_gemma":[0.3573513,0.3258442,0.3066292,0.0001247621,0.003250184,0.0004054685,0.0001145725,0.0008255981,0.003315646,0.000138895,0.001953399,0.00004695815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974738,0.00168611,0.00002905278,0.00006211365,0.00002197443,0.0001381486,0.0002132055,0.000006203199,0.0003694315],"genre_scores_gemma":[0.9978428,0.000581706,0.0002410133,0.0001774905,0.00007641602,0.0001182803,0.0007051129,0.000003065349,0.0002542003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002549854,"threshold_uncertainty_score":0.01348507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04127527816945441,"score_gpt":0.3057741080965317,"score_spread":0.2644988299270773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}